EP1515728A2 - Utilisation de derives de prostacycline disponibles par voie orale pour preparer un produit pharmaceutique pour traiter des maladies qui sont associees a des oedemes de la moelle epiniere - Google Patents
Utilisation de derives de prostacycline disponibles par voie orale pour preparer un produit pharmaceutique pour traiter des maladies qui sont associees a des oedemes de la moelle epiniereInfo
- Publication number
- EP1515728A2 EP1515728A2 EP03735573A EP03735573A EP1515728A2 EP 1515728 A2 EP1515728 A2 EP 1515728A2 EP 03735573 A EP03735573 A EP 03735573A EP 03735573 A EP03735573 A EP 03735573A EP 1515728 A2 EP1515728 A2 EP 1515728A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- hydroxy
- medicament
- group
- lloprost
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10225551A DE10225551A1 (de) | 2002-06-06 | 2002-06-06 | Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind |
DE10225551 | 2002-06-06 | ||
PCT/EP2003/005990 WO2003103681A2 (fr) | 2002-06-06 | 2003-06-05 | Utilisation de derives de prostacycline disponibles par voie orale pour preparer un produit pharmaceutique pour traiter des maladies qui sont associees a des oedemes de la moelle epiniere |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1515728A2 true EP1515728A2 (fr) | 2005-03-23 |
Family
ID=29594336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03735573A Withdrawn EP1515728A2 (fr) | 2002-06-06 | 2003-06-05 | Utilisation de derives de prostacycline disponibles par voie orale pour preparer un produit pharmaceutique pour traiter des maladies qui sont associees a des oedemes de la moelle epiniere |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1515728A2 (fr) |
JP (1) | JP2005536476A (fr) |
KR (1) | KR20050007591A (fr) |
CN (1) | CN1658882A (fr) |
AU (1) | AU2003236715A1 (fr) |
CA (1) | CA2488861A1 (fr) |
DE (1) | DE10225551A1 (fr) |
WO (1) | WO2003103681A2 (fr) |
ZA (1) | ZA200500097B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5415771B2 (ja) * | 2006-02-03 | 2014-02-12 | アクテリオン ワン エスエー | 新規なエポプロステノール製剤およびその製造方法 |
TWI520740B (zh) * | 2011-02-02 | 2016-02-11 | 模範健康科技私人企業有限公司 | 利用多硫酸化多醣之骨髓水腫(水腫)的治療 |
EP3675909B1 (fr) * | 2017-08-31 | 2023-10-18 | Charité Universitätsmedizin Berlin | Immunomodulation pour la prévention d'une mauvaise cicatrisation de lésions musculo-squelettiques chez des patients fragilisés |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3608088C2 (de) * | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
DE59305822D1 (de) * | 1992-08-07 | 1997-04-17 | Schering Ag | Verwendung von prostanderivaten zur herstellung eines arzneimittels zur behandlung der chronischen polyarthritis |
WO1999013880A1 (fr) * | 1997-09-16 | 1999-03-25 | Toray Industries, Inc. | Inhibiteur de la production de chemokine c-c |
AU2002212996A1 (en) * | 2000-09-28 | 2002-04-08 | Non-Invasive Monitoring Systems, Inc. | External addition of pulses to fluid channels of body to release or suppress endothelial mediators and to determine effectiveness of such intervention |
-
2002
- 2002-06-06 DE DE10225551A patent/DE10225551A1/de not_active Ceased
-
2003
- 2003-06-05 AU AU2003236715A patent/AU2003236715A1/en not_active Abandoned
- 2003-06-05 CA CA002488861A patent/CA2488861A1/fr not_active Abandoned
- 2003-06-05 EP EP03735573A patent/EP1515728A2/fr not_active Withdrawn
- 2003-06-05 WO PCT/EP2003/005990 patent/WO2003103681A2/fr not_active Application Discontinuation
- 2003-06-05 JP JP2004510800A patent/JP2005536476A/ja active Pending
- 2003-06-05 CN CN038129760A patent/CN1658882A/zh active Pending
- 2003-06-05 KR KR10-2004-7019813A patent/KR20050007591A/ko not_active Application Discontinuation
-
2005
- 2005-01-05 ZA ZA200500097A patent/ZA200500097B/en unknown
Non-Patent Citations (1)
Title |
---|
See references of WO03103681A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003103681A3 (fr) | 2004-03-25 |
CN1658882A (zh) | 2005-08-24 |
CA2488861A1 (fr) | 2003-12-18 |
WO2003103681A2 (fr) | 2003-12-18 |
JP2005536476A (ja) | 2005-12-02 |
DE10225551A1 (de) | 2003-12-24 |
KR20050007591A (ko) | 2005-01-19 |
AU2003236715A1 (en) | 2003-12-22 |
ZA200500097B (en) | 2006-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69629184T2 (de) | Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus | |
DE69737066T2 (de) | Verwendung von aktivem Vitamin D analog zur Behandlung von Prostataerkrankungen | |
DE69722401T2 (de) | Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods | |
JP3623962B2 (ja) | ヒドロキソコバラミンの鼻中投与用医薬組成物 | |
DE60019436T2 (de) | Verwendung von nikotin oder derivaten davon und l-dopa in einem medikament zur behandlung von neurologischen erkrankungen, insbesondere der parkinson-erkrankung | |
EP1216046B1 (fr) | Nouvelle association de loteprednol et de produits antihistaminiques | |
EP1265615A2 (fr) | Nouvelle combinaison d'antihistaminiques non sedatifs et de substances qui influencent l'effet du leucotriene, pour le traitement de la rhinite/conjonctivite | |
EP0413171A1 (fr) | Produit analgésique puissant et son procédé de préparation | |
WO1998035682A1 (fr) | Agent avec trois composants hormonaux pour la contraception hormonale et/ou la prophylaxie de tumeurs des glandes mammaires | |
EP0521388B1 (fr) | Procédé de préparation d'une composition pharmaceutique à base d'au mains deux principes actifs différents et utilisation d'une telle composition | |
DE60029340T2 (de) | Pharmazeutische zusammenstellungen enthaltend einen p2t rezeptor antagonist und melagatran | |
DE69826132T2 (de) | Pharmazeutisches kombinationspräparat aus parathormon und einem inhibitor der knochenresorption | |
EP0125634A1 (fr) | Utilisation d'une substance sécrétolytique pour l'obtention d'un agent contre le ronflement et pour combattre le phénomène de ronflement | |
DE4328217C2 (de) | Therapeutisches System zur Behandlung der Psoriasis | |
EP1830835A1 (fr) | Utilisation d'un agoniste de recepteur vanilloide avec un glucosamine glycane ou proteoglycane pour la production d'une substance destinee a traiter les douleurs articulaires et procede d'application de ladite substance | |
DE3033545A1 (de) | Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden | |
DE2353797A1 (de) | Stabilisierung von prostaglandinen | |
EP0179421A2 (fr) | Antigestagènes, glucocorticoides et prostaglandines pour le déclenchement de l'accouchement ou pour l'interruption de la grossesse | |
EP1515728A2 (fr) | Utilisation de derives de prostacycline disponibles par voie orale pour preparer un produit pharmaceutique pour traiter des maladies qui sont associees a des oedemes de la moelle epiniere | |
US20050101673A1 (en) | Use of orally available prostacyclin derivatives for the production of a pharmaceutical agent for treating diseases that are associated with bone marrow edemas | |
DE60007179T2 (de) | Pantothensäure-enthaltende arzneimittel zur behandlung von entzündlichen gelenkserkrankungen | |
EP3407899B1 (fr) | Prophylaxie immunitaire pour des infections bactériennes récidivantes | |
EP0484581B1 (fr) | Utilisation des antagonistes du thromboxanne-A2 pour prévenir les processus dégénératifs des tissus pénils | |
EP2120918B1 (fr) | Composition pharmaceutique pour le traitement de l'incontinence | |
CA2219354A1 (fr) | Prevention des pertes de dnets par l'administration d'alendronate ou de ses sels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050103 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1076381 Country of ref document: HK |
|
17Q | First examination report despatched |
Effective date: 20060217 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BAYER SCHERING PHARMA AG |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080318 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1076381 Country of ref document: HK |